ARUP's Laboratory Test Directory

CDKL5-Related Disorders (CDKL5) Sequencing and Deletion/Duplication : 2004935
[ image for: Patient History for Rett Syndrome (MECP2) or CDKL5-Related Disorders (CDKL5) Testing]
Patient History for Rett Syndrome (MECP2) or CDKL5-Related Disorders (CDKL5) Testing
  


Mnemonic: CDKL5 FGA

Methodology: Polymerase Chain Reaction/Sequencing/Multiplex Ligation-dependent Probe Amplification
Performed: Varies
Reported: 35 days
Specimen Required: Collect: Lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B).

Specimen Preparation: Transport 3 mL whole blood. (Min: 2 mL)

Storage/Transport Temperature: Refrigerated.

Stability (collection to initiation of testing): Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable

Interpretive Data: Background Information for CDKL5-Related Disorders (CDKL5) Sequencing and Deletion/Duplication:
Characteristics:
Vary widely but may include early onset intractable seizures, severe developmental delay, with females often exhibiting features of Rett syndrome.
Incidence
: Unknown; more frequent in females than males.
Inheritance:
X-linked dominant; reported cases are de novo.
Penetrance:
100 percent.
Cause:
Pathogenic CDKL5 gene mutations.
Clinical Sensitivity:
Approximately 17 percent in females with infantile spasms or seizures.
Methodology:
Bidirectional sequencing of the CDKL5 coding region and intron-exon boundaries. Multiplex ligation-dependent probe amplification (MLPA) to detect large CDKL5 coding region deletions/duplications.
Analytical Sensitivity and Specificity of Sequencing and MLPA
: 99 percent.
Limitations
: Rare diagnostic errors can occur due to primer or probe site mutations. Regulatory region mutations and deep intronic mutations will not be detected. Large deletions/duplications of exon 3 will not be detected. The breakpoints of large deletions/duplications will not be determined.



Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

Refer to Statement C under Testing Information at http://www.aruplab.com.
CPT Code(s): Sequencing: 83891 Isolation; 83898 x26 Amplification; 83904 x26 Sequencing; 83909 Capillary electrophoresis; 83912 Interpretation and report. DelDup: 83896 x21 Nucleic Acid Probes; 83898 x21 Amplification; 83914 x21 Extension; 83909 Capillary Electrophoresis - Additional CPT code modifiers may be required for procedures performed to test for oncologic or inherited disorders.
Cross References: Atypical Rett (CDKL5-Related Disorders (CDKL5) Sequencing and Deletion/Duplication) , Epileptic Encephalopathy, Early Infantile 2 (CDKL5-Related Disorders (CDKL5) Sequencing and Deletion/Duplication) , Infantile Spasms/Atypical Rett (CDKL5-Related Disorders (CDKL5) Sequencing and Deletion/Duplication) , Rett-Like Syndrome (CDKL5-Related Disorders (CDKL5) Sequencing and Deletion/Duplication)
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org